Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Biochemical Journal|August 13, 2011
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A(2) inhibitor, displays antitumour activitySandra Donnini, Federica Finetti, Simona Francese, et al.
Biochimica Et Biophysica Acta. General Subjects|January 18, 2017
Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cellsCinzia Della Giovampaola, Antonietta Capone, Leonardo Ermini, et al.
Blood|January 11, 2008
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrinSimonetta Soro, Angela Orecchia, Lucia Morbidelli, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4Sandra Donnini, Raffaella Solito, Martina Monti, et al.
Cancers|December 10, 2021
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender ProspectiveAndrea Spini, Rosa Gini, Pietro Rosellini, et al.
Oncogene|May 29, 2002
N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growthElissavet Hatzi, Carol Murphy, Andreas Zoephel, et al.
Bioorganic & Medicinal Chemistry|March 23, 2011
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moietyGermano Giuliani, Andrea Cappelli, Mario Matarrese, et al.
Journal of Medicinal Chemistry|March 5, 2004
A non-peptide NK1 receptor agonist showing subpicomolar affinityAndrea Cappelli, Germano Giuliani, Gal la Pericot Mohr Gl, et al.
Angiogenesis|February 18, 2011
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivoJu-Ching Yeh, Tereza Cindrova-Davies, Mirella Belleri, et al.
Cancer Research|November 3, 2004
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expressionJeanette Woolard, Wen-Ying Wang, Heather S Bevan, et al.
Pageof 10